Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells

  • Krisztian Csomos
  • , Boglarka Ujhazi
  • , Peter Blazso
  • , Jose L. Herrera
  • , Christopher M. Tipton
  • , Tomoki Kawai
  • , Sumai Gordon
  • , Maryssa Ellison
  • , Kevin Wu
  • , Matthew Stowell
  • , Lauren Haynes
  • , Rachel Cruz
  • , Bence Zakota
  • , Johnny Nguyen
  • , Michelle Altrich
  • , Christoph B. Geier
  • , Svetlana Sharapova
  • , Joseph F. Dasso
  • , Jennifer W. Leiding
  • , Grace Smith
  • Waleed Al-Herz, Mayra de Barros Dorna, Olajumoke Fadugba, Eva Fronkova, Veronika Kanderova, Michael Svaton, Sarah E. Henrickson, Joseph D. Hernandez, Taco Kuijpers, Snezhina Mihailova Kandilarova, Elizaveta Naumova, Tomas Milota, Anna Sediva, Despina Moshous, Benedicte Neven, Tara Saco, Ravishankar Sargur, Sinisa Savic, John Sleasman, Gauri Sunkersett, Brant R. Ward, Masanobu Komatsu, Stefania Pittaluga, Attila Kumanovics, Manish J. Butte, Michael P. Cancro, Shiv Pillai, Eric Meffre, Luigi D. Notarangelo, Jolan E. Walter
  • University of South Florida
  • University of Szeged
  • Johns Hopkins University
  • Emory University
  • National Institutes of Health
  • Eurofins Viracor Laboratories
  • Immunology Outpatient Clinic
  • Belarusian Research Center for Pediatric Oncology
  • Kuwait University
  • Universidade de São Paulo
  • University of Pennsylvania
  • Charles University
  • The Children's Hospital of Philadelphia
  • Stanford University
  • University of Amsterdam
  • Medical University Sofia
  • Université Paris Cité
  • Institut Imagine
  • Windom Allergy
  • Sheffield Teaching Hospitals NHS Foundation Trust
  • Leeds Teaching Hospitals NHS Trust
  • St James’s University Hospital
  • Duke University
  • Virginia Commonwealth University
  • Mayo Clinic Rochester, MN
  • University of California at Los Angeles
  • Massachusetts Institute of Technology
  • Yale University
  • Massachusetts General Hospital

Producción científicarevisión exhaustiva

35 Citas (Scopus)

Resumen

The recombination-activating genes (RAG) 1 and 2 are indispensable for diversifying the primary B cell receptor repertoire and pruning self-reactive clones via receptor editing in the bone marrow; however, the impact of RAG1/RAG2 on peripheral tolerance is unknown. Partial RAG deficiency (pRD) manifesting with late-onset immune dysregulation represents an ‘experiment of nature’ to explore this conundrum. By studying B cell development and subset-specific repertoires in pRD, we demonstrate that reduced RAG activity impinges on peripheral tolerance through the generation of a restricted primary B cell repertoire, persistent antigenic stimulation and an inflammatory milieu with elevated B cell-activating factor. This unique environment gradually provokes profound B cell dysregulation with widespread activation, remarkable extrafollicular maturation and persistence, expansion and somatic diversification of self-reactive clones. Through the model of pRD, we reveal a RAG-dependent ‘domino effect’ that impacts stringency of tolerance and B cell fate in the periphery.

Idioma originalEnglish
Páginas (desde-hasta)1256-1272
Número de páginas17
PublicaciónNature Immunology
Volumen23
N.º8
DOI
EstadoPublished - ago 2022
Publicado de forma externa

Huella

Profundice en los temas de investigación de 'Partial RAG deficiency in humans induces dysregulated peripheral lymphocyte development and humoral tolerance defect with accumulation of T-bet+ B cells'. En conjunto forman una huella única.

Citar esto